Amgen Receives FDA Approval For Leukemia Drug Way Ahead Of Schedule
December 05, 2014 at 12:00 PM EST
Accelerated approval for Blincyto seems to be having mixed effect on AMGN stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.